Chronic immune checkpoint inhibitor pneumonitis.
Jarushka NaidooTricia R CottrellEvan J LipsonPatrick M FordePeter B IlleiLonny B YarmusK Ranh VoongDavid Feller-KopmanHans LeeJoanne RiemerDaphne WangJanis M TaubeJulie R BrahmerCheng Ting LinSonye K DanoffFranco R D'AlessioKarthik SureshPublished in: Journal for immunotherapy of cancer (2021)
A subset of patients who develop pneumonitis from ICIs will develop chronic ICI pneumonitis, that warrants long-term immunosuppression of ≥12 weeks, and has distinct clinicopathological features.